Cargando…
Treatment of Cholesterol Embolism With Corticosteroids and Alprostadil
Cholesterol embolism is a rare but serious disease that can lead to chronic renal failure or death. Despite the recent increase in the incidence of this disease, there is no consensus on the optimal treatment modality. Supportive care is usually the mainstay of treatment. We report a case of cholest...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Geriatrics Society
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7387603/ https://www.ncbi.nlm.nih.gov/pubmed/32743283 http://dx.doi.org/10.4235/agmr.18.0045 |
_version_ | 1783564157578117120 |
---|---|
author | Jung, Seung Mook |
author_facet | Jung, Seung Mook |
author_sort | Jung, Seung Mook |
collection | PubMed |
description | Cholesterol embolism is a rare but serious disease that can lead to chronic renal failure or death. Despite the recent increase in the incidence of this disease, there is no consensus on the optimal treatment modality. Supportive care is usually the mainstay of treatment. We report a case of cholesterol embolism after renal artery stenting that was successfully treated with corticosteroids and alprostadil. |
format | Online Article Text |
id | pubmed-7387603 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Korean Geriatrics Society |
record_format | MEDLINE/PubMed |
spelling | pubmed-73876032020-07-30 Treatment of Cholesterol Embolism With Corticosteroids and Alprostadil Jung, Seung Mook Ann Geriatr Med Res Case Report Cholesterol embolism is a rare but serious disease that can lead to chronic renal failure or death. Despite the recent increase in the incidence of this disease, there is no consensus on the optimal treatment modality. Supportive care is usually the mainstay of treatment. We report a case of cholesterol embolism after renal artery stenting that was successfully treated with corticosteroids and alprostadil. Korean Geriatrics Society 2019-03 2019-03-31 /pmc/articles/PMC7387603/ /pubmed/32743283 http://dx.doi.org/10.4235/agmr.18.0045 Text en Copyright © 2019 by The Korean Geriatric Society This is an open access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Case Report Jung, Seung Mook Treatment of Cholesterol Embolism With Corticosteroids and Alprostadil |
title | Treatment of Cholesterol Embolism With Corticosteroids and Alprostadil |
title_full | Treatment of Cholesterol Embolism With Corticosteroids and Alprostadil |
title_fullStr | Treatment of Cholesterol Embolism With Corticosteroids and Alprostadil |
title_full_unstemmed | Treatment of Cholesterol Embolism With Corticosteroids and Alprostadil |
title_short | Treatment of Cholesterol Embolism With Corticosteroids and Alprostadil |
title_sort | treatment of cholesterol embolism with corticosteroids and alprostadil |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7387603/ https://www.ncbi.nlm.nih.gov/pubmed/32743283 http://dx.doi.org/10.4235/agmr.18.0045 |
work_keys_str_mv | AT jungseungmook treatmentofcholesterolembolismwithcorticosteroidsandalprostadil |